Navigation Links
Ansell Opens New Research and Development Centre in Sri Lanka
Date:2/7/2013

ISELIN, New Jersey, February 7, 2013 /PRNewswire/ --

Ansell, a global leader in protection solutions, announces that the recently constructed 16,000 square foot state-of-the-art research and development (R&D) facility in the Biyagama Export Zone outside Colombo, Sri Lanka is now fully operational.  The Sri Lanka R&D center is the fourth center of excellence Ansell has installed-adding to its existing Malaysia, Mexico and North America-based centers. The investment in additional R&D resources and the decision to create and co-locate its R&D centers with the Ansell manufacturing structure underline the company's commitment to accelerate innovation and to faster serve the emerging unmet needs of customers worldwide.

"Ansell has a long track record of manufacturing high quality industrial and medical products in Sri Lanka, and new product development will now complement manufacturing and expand our presence in the region," said Magnus Nicolin , Managing Director and CEO of Ansell Limited, "This is a measure of the confidence in and commitment of Ansell to the talent and future of Sri Lanka."

In total, 30 science and technology specialists have been recruited, bringing along the latest technology and knowledge on both the material side as well as the manufacturing processes side.

"With over two decades in Sri Lanka and over 2000 employees, Ansell has been a key player in Sri Lanka's export industry for a very long time," said Sujatha Weerakoon Director General of the Sri Lanka Export Development Board.   "I am confident that the new R&D Center will greatly help further establish the role of Ansell as a local business leader while also benefitting the national economy."

BOI Chairman/Director General Dr Lakshman Jayaweera said: "I am very pleased that a distinguished Australian company such as Ansell, which has been a long-standing investor under the BOI, has opened an R&D facility in Sri Lanka. Research and Development is an essential component in any enterprise's production process and can influence decisions to invest in a country. Furthermore, investments that develop innovation sector such as Ansell's new R & D facility are also in line with the strategic plan of the Government to transform Sri Lanka into a Knowledge Hub." 

Ansell product leadership is a result of ongoing investment to deliver new market leading innovative technologies to serve customer demand for high-quality products that seamlessly combine safety with comfort.  

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being.

With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 11,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.

Information on Ansell and its products can be found at http://www.ansell.com 


'/>"/>
SOURCE Ansell
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ansell Limited and Ramsay Health Care Enter Global Multi-Year Purchasing Agreement
2. Ansell Extends Antimicrobial Product Offering with New Non-latex Surgical Glove
3. Ansell erweitert antimikrobielles Produktangebot mit einem neuen latexfreien Operationshandschuh
4. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
5. Ansell y Comasec presentan Shared World of Innovation en ExpoProtection 2012
6. Ansell and Child in Hand Announce Completion of Critical Community Projects in Haiti
7. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
8. Synchrogenix Opens in Sweden
9. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
10. Marken Opens Branch Office In Seoul, South Korea
11. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Patient ... Baltimore Health System, with the 2017 Ruth Ravich Patient Advocacy Award in ... patient advocates. DeVaro was honored with the award at The Beryl Institute’s annual ...
(Date:4/21/2017)... ... April 21, 2017 , ... The ... A Week of Addiction and Recovery Education, from April 24 to April 28, ... substance use disorders. , The mission of AWARE is to instill a ...
(Date:4/21/2017)... UK (PRWEB) , ... April 21, 2017 , ... ... for Enterprise in the category of International Trade, the UK’s most prestigious award ... international trade, which represents 95% of total revenues and has grown by a ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal ... five common elements between the Obamacare program that most Republicans love to hate ... Warfarin poison to kill hogs. , Like Obamacare, the Miller program centers ...
Breaking Medicine News(10 mins):